Identification of the Schistosoma mansoni Molecular Target for the Antimalarial Drug Artemether
KAUST Grant NumberKUK-I1-012-43
Permanent link to this recordhttp://hdl.handle.net/10754/598550
MetadataShow full item record
AbstractPlasmodium falciparum and Schistosoma mansonii are the parasites responsible for most of the malaria and schistosomiasis cases in the world. Notwithstanding their many differences, the two agents have striking similarities in that they both are blood feeders and are targets of an overlapping set of drugs, including the well-known artemether molecule. Here we explore the possibility of using the known information about the mode of action of artemether in Plasmodium to identify the molecular target of the drug in Schistosoma and provide evidence that artemether binds to SmSERCA, a putative Ca2+-ATPase of Schistosoma. We also predict the putative binding mode of the molecule for both its Plasmodium and Schistosoma targets. Our analysis of the mode of binding of artemether to Ca2+-ATPases also provides an explanation for the apparent paradox that, although the molecule has no side effect in humans, it has been shown to possess antitumoral activity. © 2011 American Chemical Society.
CitationLepore R, Simeoni S, Raimondo D, Caroli A, Tramontano A, et al. (2011) Identification of the Schistosoma mansoni Molecular Target for the Antimalarial Drug Artemether. J Chem Inf Model 51: 3005–3016. Available: http://dx.doi.org/10.1021/ci2001764.
SponsorsWe thank all our colleagues of the Biocomputing Unit and the members of the Fondazione Roma Research Unit led by Prof. Maurizio Brunori for useful discussions. This work was partially supported by award number KUK-I1-012-43 made by King Abdullah University of Science and Technology (KAUST), Human Frontier Science Program HFSP-RGP0054/2006-C grant (http://www.hfsp.org/), FIRB Italbionet and Proteomica, Ministery of Health grant contract no. Onc_Ord 25/07, Fondazione Roma, and the IIT SEED project "Advanced Computational Methods for Biophysics, Drug Design, and Energy Research".
PublisherAmerican Chemical Society (ACS)
CollectionsPublications Acknowledging KAUST Support
- Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
- Authors: Shu-Hua X, Utzinger J, Chollet J, Tanner M
- Issue date: 2006 Jul
- Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients.
- Authors: Abay SM, Tilahun M, Fikrie N, Habtewold A
- Issue date: 2013 Jun 15
- Molecular modelling based target identification for endo-peroxides class of antimalarials.
- Authors: Gupta AK, Saxena AK
- Issue date: 2015
- Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.
- Authors: Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao S, Tanner M
- Issue date: 2000 Apr 15
- Synthesis and biological evaluation of 1,4-naphthoquinones and quinoline-5,8-diones as antimalarial and schistosomicidal agents.
- Authors: Lanfranchi DA, Cesar-Rodo E, Bertrand B, Huang HH, Day L, Johann L, Elhabiri M, Becker K, Williams DL, Davioud-Charvet E
- Issue date: 2012 Aug 21